HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Goulvestre, C. Articles by Batteux, F. Search for Related Content PubMed PubMed Citation Articles by Goulvestre, C. Articles by Batteux, F.

A Mimic of p21^WAF1/CIP1 Ameliorates Murine Lupus¹

Claire Goulvestre^2,*, Christiane Chéreau^2,*, Carole Nicco^*, Luc Mouthon, Bernard Weill^* and Frédéric Batteux^3,*

^* Laboratoire d’Immunologie and Service de Médecine Interne, Faculté de Médecine René Descartes et Hôpital Cochin, Université Paris 5, Paris, France

Systemic lupus erythematosus (SLE) is a progressive autoimmune disease characterized by the production of high levels of affinity-matured IgG autoantibodies to dsDNA and, possibly, visceral involvement. Pathogenic autoantibodies result from the activation and proliferation of autoreactive T and B lymphocytes stimulated by epitopes borne by nucleosomal histones. To inhibit the proliferation of autoreactive cells and abrogate the development of SLE, a novel tool, cell cycle inhibiting peptide therapy, was used. Thus, a peptidyl mimic of p21^WAF1/CIP1 that inhibits the interaction between cyclin-dependent kinase 4 and type D cyclins abrogated the in vitro proliferative response of T cells to histones and T-independent and T-dependent proliferative responses of B cells. The ^WAF1/CIP1 mimic also abrogated the in vitro production of total and anti-dsDNA IgG Abs by B cells. Similarly, the p21^WAF1/CIP1 construct inhibited the ex vivo T and B cell proliferative responses to histones and decreased the numbers of activated/memory B and T spleen cells. The alterations in the balance of spleen cell subsets resulted from proapoptotic effects of the p21^WAF1/CIP1 construct on activated splenocytes. Finally, in vivo, four i.v. injections of the p21^WAF1/CIP1 mimic were sufficient to inhibit the progression of the lupus-like syndrome in (NZB x NZW)F₁ mice. The levels of anti-dsDNA IgG autoantibodies and the incidence and severity of renal involvement were lower in treated mice than in nontreated mice. Those observations open new avenues for the treatment of SLE and prompt us to evaluate the potential interest of peptidic therapy in human SLE.

This article has been cited by other articles:

				D. Peer, P. Zhu, C. V. Carman, J. Lieberman, and M. Shimaoka Selective gene silencing in activated leukocytes by targeting siRNAs to the integrin lymphocyte function-associated antigen-1 PNAS, March 6, 2007; 104(10): 4095 - 4100. [Abstract] [Full Text] [PDF]

				C. F. Arias, A. Ballesteros-Tato, M. I. Garcia, J. Martin-Caballero, J. M. Flores, C. Martinez-A, and D. Balomenos p21CIP1/WAF1 Controls Proliferation of Activated/Memory T Cells and Affects Homeostasis and Memory T Cell Responses J. Immunol., February 15, 2007; 178(4): 2296 - 2306. [Abstract] [Full Text] [PDF]